HEAD AND NECK NEOPLASMS
Clinical trials for HEAD AND NECK NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK NEOPLASMS trials appear
Sign up with your email to follow new studies for HEAD AND NECK NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Needle-in-Tumor cancer therapy seeks to rally Body's defenses
Disease control Not yet recruitingThis study is testing an experimental drug called N17350 for adults with advanced solid tumors that have spread or stopped responding to standard treatments. The drug is injected directly into a tumor every two weeks to try to stimulate the immune system to fight the cancer. The …
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Onchilles Pharma Inc • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
New drug duo aims to boost immune attack on tough head and neck cancers
Disease control Not yet recruitingThis early-stage study is testing whether adding an experimental drug called decitabine can make an approved immunotherapy (nivolumab) work better against recurrent or spreading head and neck cancer. The main goals are to find the safest dose of the combination and see how it aff…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE1 • Sponsor: Kyunghee Burkitt, DO, PhD • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New program aims to speed up cancer care for emergency room patients
Knowledge-focused Not yet recruitingThis pilot study is testing a community health support program designed to help head and neck cancer patients who first go to the emergency room. The program connects patients with a specialist who helps them overcome common barriers like transportation or insurance issues to get…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: NA • Sponsor: University of Tennessee • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC